The PRIMA retinal implant, a light-powered chip placed under the retina.
Science Corporation, a US brain-computer interface company, has raised $400m in a Series D round, it said in a blog post on Tuesday. The company has now raised more than $900m since it was founded in 2021.
Investors include Khosla Ventures, Tenet Healthcare, Y Combinator, 885 Capital, PLC Neurotech and the Ackman Oxman Institute, among others. Science did not name a lead investor or disclose its valuation.
The round comes eight months after Science raised a $230m Series C, which TechCrunch reported valued the company at $1.5bn.
Science is led by Max Hodak, a co-founder and former president of Neuralink. Its main product is PRIMA, a tiny chip implanted under the retina that works with a pair of camera glasses. It is designed for people who have lost central vision to geographic atrophy, a late stage of dry age-related macular degeneration.
PRIMA won a CE mark in July, allowing sales in 30 European countries.…